Study of Vedolizumab in Patients With Moderate to Severe Crohn's Disease
Clinical trial NCT01224171 · COMPLETED
Trial details
- NCT number
- NCT01224171
- Sponsor
- Millennium Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-11-01
- Primary completion
- 2012-02-01
- Enrollment
- 416
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.